Prestige Biopharma’s First-in-Class Pancreatic Cancer Treatment, PBP1510, Receives Approval for Clinical Trial in France
SINGAPORE, June 21 (Bernama-BUSINESS WIRE) — Prestige BioPharma Limited (PBP) specializing in the development of antibody therapeutics, announced that French National Agency…


